People with overactive bladders have a sudden, strong urge to urinate that makes them go to the bathroom a lot, leak, or even wake up several times at night. Many doctors say that simple changes to ...

As insurers gear up for outreach ahead of Medicare open enrollment, the SCAN Group is taking a unique stance by openly acknowledging the cracks in the system. In its new national campaign—titled ...

A young, thriving Brazilian lawyer tragically died after suffering a severe allergic reaction during a routine CT scan. Leticia Paul, 22, suffered an anaphylactic shock on Wednesday while undergoing a ...

Around 18,000 people in England are diagnosed with bladder cancer each year, and experts hope the new treatment - a combination of two drugs - will help patients spend far more time with their loved ...

Colorado coach Deion Sanders did his first advertisement for the Depend adult diaper brand after having his cancerous bladder removed in May. But it's not just the latest sponsorship deal for Sanders, ...

The NHS will roll out a new treatment for advanced bladder cancer which doubles survival time. It's estimated that 1,250 people a year could benefit from a combination of drugs called enfortumab ...

A new treatment for advanced bladder cancer which doubles survival time has been approved for NHS use. The treatment for advanced bladder cancer had not significantly changed since the 1980s. Now, ...

Leticia Paul, a 22-year-old Brazilian lawyer with a history of kidney stones, tragically passed away after experiencing a severe anaphylactic shock during a routine CT scan with contrast on August 20, ...

Hospice Whanganui chief executive Helen Leslie (left) with Rotary Whanganui North's international and medical committee chairman Tony Hodge, who is co-ordinating the fundraising campaign. Photo / Fin ...

A YOUNG law graduate has tragically died after suffering a severe allergic reaction following a CT scan. Leticia Paul, 22, was undergoing a routine check-up for kidney stones when she reacted to a ...

The National Institute for Health and Care Excellence (NICE) has recommended the combination of enfortumab vedotin (Padcev, Astellas) with pembrolizumab (Keytruda, MSD) as a first-line option for ...

THOUSANDS of Brits with bladder cancer could survive for twice as long after a new treatment was given the green light to be dished out on the NHS. Health chiefs have said the approval marks "one of ...